Omada Evernorth PBM distribution leverage
Virta Health
This partnership matters because it turns Omada from a point solution that must win one employer at a time into a program that can be merchandised inside one of the biggest pharmacy distribution rails in U.S. healthcare. Evernorth can place Omada in front of employers already buying pharmacy benefits through Express Scripts, which makes distribution cheaper, sales cycles shorter, and clinical programs easier to attach to diabetes and GLP-1 drug spend management.
-
Preferred partner status means Omada is on Evernorth’s digital health formulary for diabetes, hypertension, and prevention. In practice, that gives PBM account teams a default digital care option to sell alongside pharmacy management, instead of asking employers to source a separate vendor on their own.
-
The real asset is channel leverage, not immediate covered lives. Omada disclosed about 20 million covered lives across its current customers and channel partners as of December 31, 2023, while Evernorth and Express Scripts operate at much larger national scale. The 180 million figure describes the size of the PBM shelf, not enrolled Omada members.
-
This also explains why Omada sits in a different lane from Virta. Omada is built to fit existing payer and PBM workflows around prevention, adherence, and behavior change, while Virta sells a more intensive metabolic care model with higher revenue per customer and patient. That makes Omada easier to plug into broad formulary style distribution.
Going forward, PBMs are likely to use programs like Omada less as wellness perks and more as utilization controls tied to expensive cardiometabolic drugs. The winners in this channel will be the vendors that fit cleanly into PBM benefit design, prove lower total drug spend, and can be rolled out across thousands of employer accounts with minimal extra setup.